Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.58 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.57 |
| ▸ | RARB | P10826 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 1/20 | 0.53 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.53 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.53 |
| ▸ | F2 | P00734 | 2/20 | 0.53 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.53 |
| ▸ | PLAU | P00749 | 1/20 | 0.53 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.53 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15020066 | 1.00 | TP53 (0.59) | TP53TSHRPLA2G4BNR5A1RARB | |
| SCHEMBL7341007 | 1.00 | TP53 (0.59) | TP53TSHRPLA2G4BNR5A1RARB | |
| SCHEMBL8718224 | 0.98 | TP53 (0.57) | TP53TSHRPLA2G4BNR5A1RARB | |
| SCHEMBL6407420 | 0.95 | MMP1 (0.56) | TP53TSHRPLA2G4BGAARAB9A | |
| Pentamidine Dao SCHEMBL548448 | 0.92 | PRMT1 (0.61) | GAAPRMT1F2ST14PLAU | |
| SCHEMBL548439 | 0.90 | PRSS1 (0.60) | GAAPRMT1F2ST14PLAU | |
| SCHEMBL3275310 | 0.88 | PLK1 (0.56) | MAPTTMPRSS2CYP2D6 | |
| SCHEMBL549185 | 0.86 | TMPRSS2 (0.60) | PRMT1F2ST14PLAUPRMT5 | |
| SCHEMBL6956710 | 0.86 | TP53 (0.58) | TP53TSHRPLA2G4BNR5A1RARB | |
| SCHEMBL6957533 | 0.86 | TP53 (0.58) | TP53TSHRPLA2G4BNR5A1RARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304554-B2 | Compound, composition and thin film | FUJIFILM CORPORATION (JP) | 2012-11-06 | — | — | US | disclosed |
| US-8025933-B2 | Optical anisotropic layer | FUJIFILM CORPORATION (JP) | 2011-09-27 | — | — | US | disclosed |
| US-20100222594-A1 | Compound, composition and thin film | FUJIFILM CORPORATION (JP) | 2010-09-02 | — | — | US | disclosed |
| US-7696353-B2 | Compound, composition and thin film | FUJIFILM CORPORATION (JP) | 2010-04-13 | — | — | US | disclosed |
| US-7431971-B2 | Retardation plate | FUJIFILM CORPORATION (JP) | 2008-10-07 | — | — | US | disclosed |
| US-20080193679-A1 | Optical anisotropic layer | FUJIFILM CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080064879-A1 | Compound ,Composition And Thin Film | FUJIFILM CORPORATION (JP) | 2008-03-13 | — | — | US | disclosed |
| US-20050159355-A1 | For treatment of inflammatory diseases | YAMANOUCHI PHARMACEUTICAL CO., LTD. | 2005-07-21 | — | — | US | disclosed |
| US-20030077709-A1 | Novel leukotriene B4 receptor | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1270589-A1 | NOVEL LEUKOTRIENE B4 RECEPTOR | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 2003-01-02 | — | — | EP | disclosed |
| EP-0788511-B1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-12-11 | — | — | EP | disclosed |
| US-6265536-B1 | MICROBIOCIDE AND FUNGICIDE WHICH IS INHIBITOR OF BETA-1,3-GLUCAN SYNTHASE; TREATMENT OF PNEUMOCYSTIS CARINII INFECTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-6107458-A | FUNGICIDE WHICH IS BETA-1,3-GLYCAN SYNTHASE INHIBITOR; FOR PROPHYLAXIS AND TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS LIKE PNEUMONIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-22 | — | — | US | disclosed |
| EP-0788511-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996011210-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193679-A1 | Optical anisotropic layer | YBX1, YBX3, H1-2 | TP53 4114/4885TSHR 2424/4885PLA2G4B 4154/4885 |
| US-20100222594-A1 | Compound, composition and thin film | MATR3, Q6ZSR9, FN1 | TP53 4585/4885TSHR 2460/4885PLA2G4B 4515/4885 |
| US-20080064879-A1 | Compound ,Composition And Thin Film | YBX1, H1-2, YBX3 | TP53 3837/4885TSHR 1821/4885PLA2G4B 4586/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.